| Literature DB >> 22544393 |
Barbara Herdy1, Maritza Jaramillo1, Yuri V Svitkin1, Amy B Rosenfeld1, Mariko Kobayashi2, Derek Walsh3, Tommy Alain1, Polen Sean1, Nathaniel Robichaud1, Ivan Topisirovic1, Luc Furic4, Ryan J O Dowling1, Annie Sylvestre1, Liwei Rong5, Rodney Colina6, Mauro Costa-Mattioli7, Jörg H Fritz8, Martin Olivier9, Earl Brown10, Ian Mohr2, Nahum Sonenberg1.
Abstract
Type I interferon is an integral component of the antiviral response, and its production is tightly controlled at the levels of transcription and translation. The eukaryotic translation-initiation factor eIF4E is a rate-limiting factor whose activity is regulated by phosphorylation of Ser209. Here we found that mice and fibroblasts in which eIF4E cannot be phosphorylated were less susceptible to virus infection. More production of type I interferon, resulting from less translation of Nfkbia mRNA (which encodes the inhibitor IκBα), largely explained this phenotype. The lower abundance of IκBα resulted in enhanced activity of the transcription factor NF-κB, which promoted the production of interferon-β (IFN-β). Thus, regulated phosphorylation of eIF4E has a key role in antiviral host defense by selectively controlling the translation of an mRNA that encodes a critical suppressor of the innate antiviral response.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22544393 PMCID: PMC4032494 DOI: 10.1038/ni.2291
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606